Fabrazyme and myocardial infarction Patient Reports February 11, 2012

Fabrazyme Side Effects Report #5861326-8
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2008. Male patient, 82 years of age, weighting 187.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: 85 MG,Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4606824-X
Fabrazyme side effect was reported by a Physician from on Mar 01, 2005. Male patient, 71 years of age, weighting 142.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, clostridium colitis, confusional state, myocardial infarction, pneumonia , ventricular tachycardia. Fabrazyme dosage: unknown. During the same period patient was treated with PRAVACHOL, EPOGEN, FLOVENT, AMLODIPINE, ASPIRIN, PLAVIX, THIAMINE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5093634-5
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 64 years of age, weighting 209.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction, pulmonary embolism . Fabrazyme dosage: 85 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5108053-2
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 05, 2006. Male patient, 64 years of age, weighting 213.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction, pulmonary embolism . Fabrazyme dosage: 85 MG Q2WKS IV. During the same period patient was treated with ATENOLOL, ALLOPURINOL, LASIX, CALCITONIN, GLIPIZIDE, LOPID, IMDUR, NEURONTIN. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5484496-2
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 26, 2007. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arrhythmia , cardiac arrest , myocardial infarction. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with DICLOFENAC, BETAMETHASONE, WARFARIN POTASSIUM, ENALAPRIL MALEATE, PRECIPITATED CALCIUM CARBONATE, MECOBALAMIN, ALFACALCIDOL. Patient died on 01/08/2006.

Fabrazyme Side Effects Report #4907133-1
Fabrazyme side effect was reported by a Physician from JAPAN on Jan 23, 2006. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac arrest , myocardial infarction. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with APRINDINE HYDROCHLORIDE. Patient died on 01/08/2006.

Fabrazyme Side Effects Report #4917904-3
Fabrazyme side effect was reported by a Physician from JAPAN on Feb 07, 2006. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac arrest , feeling abnormal, myocardial infarction. Fabrazyme dosage: 70 MG Q2WS IV. During the same period patient was treated with APRINDINE HYDROCHLORIDE, DICLOFENAC, BETAMETHASONE, WARFARIN POTASSIUM. Patient died on 01/08/2006.

Fabrazyme Side Effects Report #4952174-1
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 08, 2006. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac arrest , myocardial infarction. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with APRINDINE HYDROCHLORIDE, DICLOFENAC, BETAMETHASONE, WARFARIN POTASSIUM. Patient died on 01/08/2006.

Fabrazyme Side Effects Report #5761917-9
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on May 26, 2008. Female patient, 62 years of age, weighting 124.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 05/26/2008.


Fabrazyme Side Effects Report #4767676-0
Fabrazyme side effect was reported by a Physician from DENMARK on Aug 26, 2005. Female patient, 62 years of age, weighting 175.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature increased, dizziness , fatigue, feeling hot, heart rate increased, myocardial infarction. Fabrazyme dosage: 79.5 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5408139-9
Fabrazyme side effect was reported by a Physician from ITALY on July 30, 2007. Female patient, 60 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coma, myocardial infarction. Fabrazyme dosage: 1 MG/KG Q2WKS IN. Patient was hospitalized. Patient died on 07/25/2007.

Fabrazyme Side Effects Report #6010159-0
Fabrazyme side effect was reported by a Health Professional from UNITED KINGDOM on Dec 02, 2008. Male patient, 60 years of age, weighting 108.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, dialysis , diverticular perforation, dysphagia, gastrointestinal haemorrhage, myocardial infarction, renal failure acute, small intestinal perforation. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with GABAPENTIN, ATORVASTATIN CALCIUM, RAMIPRIL, ASPIRIN, ALENDRONAT, ADCAL, ERYTHROPOIETIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4909812-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 26, 2006. Male patient, 59 years of age, weighting 130.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood pressure increased, cardiac ventricular disorder, condition aggravated, deafness, myocardial infarction, nausea , post procedural complication, scar . Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5254751-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: coronary artery occlusion, myocardial infarction, peripheral vascular disorder, vascular occlusion. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5267017-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: coronary artery occlusion, myocardial infarction, vascular occlusion. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5314640-9
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angiopathy, myocardial infarction, vascular occlusion. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5337618-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on May 14, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction, thrombosis in device. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4868471-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Dec 13, 2005. Male patient, 58 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , azotaemia, cardiopulmonary failure, cerebrovascular accident, encephalopathy, myocardial infarction, renal failure chronic, treatment noncompliance. Fabrazyme dosage: 55 MG ONCE IV. During the same period patient was treated with TOPROL, NORVASC, ALBUTEROL, PHOSLO, SPIRIVA, EPOGEN. Patient was hospitalized. Patient died on 12/05/2005.

Fabrazyme Side Effects Report #5394948-1
Fabrazyme side effect was reported by a Physician from CANADA on July 10, 2007. Male patient, 56 years of age, weighting 148.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, bundle branch block left, bundle branch block right, electrocardiogram st-t change, gastritis, left atrial dilatation, myocardial infarction, pain in extremity, tricuspid valve incompetence. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PLAVIX, HYDROCHLOROTHIAZIDE, COUMADIN, METOPROLOL SUCCINATE, NITROGLYCERIN, LIPITOR, MONOCOR, ALTACE. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #4583502-7
Fabrazyme side effect was reported by a Physician from on Feb 01, 2005. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, coronary artery stenosis, disease progression, myocardial infarction, paraesthesia, renal failure, tachyarrhythmia, temperature intolerance, transient ischaemic attack. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with DELIX, ASPIRIN, PLAVIX, NEXIUM, CONCOR, SORTIS. Patient recovered.

Fabrazyme Side Effects Report #4751541-9
Fabrazyme side effect was reported by a Physician from GERMANY on Aug 11, 2005. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, coronary artery stenosis, disease recurrence, myocardial infarction, paraesthesia, renal failure, tachyarrhythmia, temperature intolerance. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with DELIX, ASPIRIN, PLAVIX, NEXIUM, CONCOR, SORTIS. Patient recovered.

Fabrazyme Side Effects Report #4947263-1
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2006. Male patient, 53 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: 50 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4982659-3
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Apr 06, 2006. Male patient, 53 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: hyperlipidaemia, infusion related reaction, myocardial infarction. Fabrazyme dosage: 50 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5348587-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on May 23, 2007. Male patient, 52 years of age, weighting 112.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood creatinine increased, chronic obstructive pulmonary disease, myocardial infarction. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ASPIRIN, CALCITRIOL, DECADRON, DUONEBS, LEVAQUIN, NICOTINE. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5805245-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on June 26, 2008. Male patient, 52 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: drowning , fall , myocardial infarction. Fabrazyme dosage: 85 MG, Q2W, INTRAVENOUS. Patient died on 06/01/2008.

Fabrazyme Side Effects Report #5207261-X
Fabrazyme side effect was reported by a Pharmacist from UNITED STATES on Dec 27, 2006. Female patient, 51 years of age, weighting 160.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5219095-0
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2007. Male patient, 50 years of age, weighting 242.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: 55 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4698410-0
Fabrazyme side effect was reported by a Consumer or non-health professional from on June 02, 2005. Female patient, 50 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: unknown. Patient died on 05/10/2004.

Fabrazyme Side Effects Report #4701933-9
Fabrazyme side effect was reported by a Consumer or non-health professional from on June 13, 2005. Male patient, 50 years of age, weighting 231.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: localised infection, myocardial infarction. Fabrazyme dosage: 105 MG Q2WKS IV. During the same period patient was treated with DIOVAN, BUMEX, COUMADIN. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #4707848-4
Fabrazyme side effect was reported by a Physician from CANADA on June 22, 2005. Male patient, 50 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: economic problem, myocardial infarction. Fabrazyme dosage: unknown. Patient died on 05/10/2004.

Fabrazyme Side Effects Report #4708978-3
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 22, 2005. Male patient, 50 years of age, weighting 105.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation , cellulitis , electrocardiogram st segment depression, hyperkeratosis, myocardial infarction, skin ulcer, soft tissue infection. Fabrazyme dosage: unknown. During the same period patient was treated with DIOVAN, BUMEX, COUMADIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4719242-0
Fabrazyme side effect was reported by a Physician from CANADA on July 08, 2005. Male patient, 50 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: 1 MG/KG IV. Patient died on 05/10/2004.

Fabrazyme Side Effects Report #5354586-3
Fabrazyme side effect was reported by a Physician from JAPAN on May 28, 2007. Male patient, 47 years of age, weighting 172.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrioventricular block complete, cardio-respiratory arrest, foreign body trauma, injury asphyxiation, loss of consciousness, myocardial infarction, nasopharyngitis. Fabrazyme dosage: 80 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, LEVOTHYROXINE, FAMOTIDINE, MAXACALCITOL, AMEZINIUM METILSULPHATE, DROXIDOPA, CLOPERASTINE FENDIZOATE. Patient died on 12/09/2005.

Fabrazyme Side Effects Report #5363462-1
Fabrazyme side effect was reported by a Physician from JAPAN on June 12, 2007. Male patient, 47 years of age, weighting 172.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: accidental exposure, atrioventricular block complete, foreign body trauma, hypertrophic cardiomyopathy, injury asphyxiation, loss of consciousness, myocardial infarction, nasopharyngitis, renal failure. Fabrazyme dosage: 80 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, LEVOTHYROXINE, FAMOTIDINE, MAXACALCITOL, AMEZINIUM METILSULPHATE, DROXIDOPA, CLOPERASTINE FENDIZOATE. Patient was hospitalized. Patient died on 12/09/2005.


Fabrazyme Side Effects Report #5179444-9
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2006. Male patient, 47 years of age, weighting 145.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5189867-X
Fabrazyme side effect was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient, 47 years of age, weighting 145.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: myocardial infarction, peritoneal dialysis. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4551470-X
Fabrazyme side effect was reported by a Consumer or non-health professional from on Dec 28, 2004. Male patient, 45 years of age, weighting 145.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: loss of consciousness, myocardial infarction, peritoneal dialysis, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with NORVASC, TOPROL, ALBUTEROL, PAXIL, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5876634-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 27, 2008. Male patient, 44 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , blood pressure increased, chest discomfort, chills, erythema, infusion related reaction, myocardial infarction, nausea . Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient died on 07/25/2008.

Fabrazyme Side Effects Report #5876634-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 27, 2008. Male patient, 44 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , blood pressure increased, chest discomfort, chills, erythema, infusion related reaction, myocardial infarction, nausea . Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient died on 07/25/2008.


Fabrazyme Side Effects Report #6112247-7
Fabrazyme side effect was reported by a Physician from SOUTH AFRICA on Feb 26, 2009. Male patient, 34 years of age, weighting 246.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, myocardial infarction, pulmonary embolism . Fabrazyme dosage: 105 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ATORVASTATIN CALCIUM, EZETIMIBE, IRBESARTAN, VERAPAMIL, COLCHICINE, PANTOPRAZOLE, TOPIRAMATE. Patient died on 02/25/2009.

Fabrazyme Side Effects Report #5585986-4
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 26, 2007. Female patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arterial disorder, iliac artery occlusion, myocardial infarction, thrombosis in device, vascular occlusion. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5917213-X
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2008. Female patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: iliac artery occlusion, myocardial infarction, peripheral vascular disorder, vascular occlusion. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with COUMADIN, METOPROLOL TARTRATE, HYZAAR, ASPIRIN, WELLBUTRIN, LIPITOR, METFORMIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5957751-7
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Female patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arterial disorder, glucose tolerance impaired, iliac artery occlusion, myocardial infarction, peripheral vascular disorder, thrombosis in device, vascular occlusion. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with COUMADIN, METOPROLOL TARTRATE, HYZAAR, ASPIRIN, WELLBUTRIN, LIPITOR, METFORMIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #6122002-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2009. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cerebrovascular accident, dizziness , myocardial infarction. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.